409 related articles for article (PubMed ID: 29452091)
1. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
[TBL] [Abstract][Full Text] [Related]
3. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
[TBL] [Abstract][Full Text] [Related]
4. [Expression and Clinical Significance of Galcetin-3 in the Serum of Non-small Cell Lung Cancer Patients].
Qi D; Zhang Y; Li H; Wang R; Qian K
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):333-336. PubMed ID: 32429635
[TBL] [Abstract][Full Text] [Related]
5. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis.
Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y
J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916
[TBL] [Abstract][Full Text] [Related]
8. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
9. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C
J Vis Exp; 2016 May; (111):. PubMed ID: 27285610
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell-derived exosomal circUSP7 induces CD8
Chen SW; Zhu SQ; Pei X; Qiu BQ; Xiong D; Long X; Lin K; Lu F; Xu JJ; Wu YB
Mol Cancer; 2021 Nov; 20(1):144. PubMed ID: 34753486
[TBL] [Abstract][Full Text] [Related]
12. Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer.
Chang W; Zhu J; Yang D; Shang A; Sun Z; Quan W; Li D
Respir Res; 2023 May; 24(1):140. PubMed ID: 37259101
[TBL] [Abstract][Full Text] [Related]
13. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
14. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
Grimolizzi F; Monaco F; Leoni F; Bracci M; Staffolani S; Bersaglieri C; Gaetani S; Valentino M; Amati M; Rubini C; Saccucci F; Neuzil J; Tomasetti M; Santarelli L
Sci Rep; 2017 Nov; 7(1):15277. PubMed ID: 29127370
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Protein Profiling and mRNA Expression of LLC Exosomes.
Zhang W; He P; Wang S; Adili A; Chen Z; Zhang CY; Jiang X; Li J; Zhang Y
Protein J; 2019 Oct; 38(5):586-597. PubMed ID: 31214853
[TBL] [Abstract][Full Text] [Related]
17. The mtDNA fragments within exosomes might be novel diagnostic biomarkers of non-small cell lung cancer.
Lou C; Ma X; Chen Z; Zhao Y; Yao Q; Zhou C; Zhao X; Meng X
Pathol Res Pract; 2023 Sep; 249():154718. PubMed ID: 37544132
[TBL] [Abstract][Full Text] [Related]
18. Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells.
Pan D; Chen J; Feng C; Wu W; Wang Y; Tong J; Zhou D
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646616
[TBL] [Abstract][Full Text] [Related]
19. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer.
Bai J; Li X; Tong D; Shi W; Song H; Li Q
Tumour Biol; 2013 Apr; 34(2):805-9. PubMed ID: 23359271
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer.
Su Y; Yamazaki S; Morisue R; Suzuki J; Yoshikawa T; Nakatsura T; Tsuboi M; Ochiai A; Ishii G
Pathobiology; 2021; 88(3):218-227. PubMed ID: 33321503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
